GlucoTrack
GCTK
7 hedge funds and large institutions have $273K invested in GlucoTrack in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
68% more capital invested
Capital invested by funds: $163K → $273K (+$110K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
13% less funds holding
Funds holding: 8 → 7 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$48.6K |
| 2 |
VCM
Virtue Capital Management
Brentwood,
Tennessee
|
+$7.84K |
| 3 |
Renaissance Technologies
New York
|
+$3.14K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boston Financial Management
Boston,
Massachusetts
|
-$6.9K |
| 2 |
VF
Virtu Financial
New York
|
-$5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$4.71K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$3.48K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.26K |
GCTK Hedge Fund Activity: Q1 2024 in Review
7 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q1 2024, worth a combined $273K — up 68% from $163K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of GCTK and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, adding an estimated $48.6K. The largest seller was Boston Financial Management, exiting entirely with an estimated $6.9K sold.
- 7 institutional investors held GlucoTrack (GCTK) as of Q1 2024, down from 8 in Q4 2023.
- Funds reported $273K of GlucoTrack stock for Q1 2024, up 68% quarter-over-quarter.
- 3 funds opened new GlucoTrack positions in Q1 2024 and 4 closed out, a net change of -1 holder.
- The largest GlucoTrack buyer in Q1 2024 was Sabby Management, an estimated $48.6K added.
- The largest GlucoTrack seller in Q1 2024 was Boston Financial Management, an estimated $6.9K sold.
Based on aggregated 13F filings for Q1 2024.